Pharma times RSS Feed

Data shows a range of responses in different tumours

Investors include SV Health Investors and Cancer Research UK

Detailed results presented at ESMO also show benefit in prostate cancer

Positive opinions include Pacira's Exparel and two new vaccines from Sanofi

The drug has been approved for routine NHS commissioning for squamous or non-squamous NSCLC

Tumour agnostic therapy demonstrates sustained efficacy

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)

The deadline for entering the 2020 PharmaTimes Communications Awards, Sales Awards and Marketer of the Year competitions has been extended to Friday October 2 after a last-minute spike in enquiries

Industry body says in vitro diagnostics are vital to clearing the backlog of undiagnosed conditions

Over half of patients treated with combination therapy were alive and relapse-free after five years

AZ will take the programme forward into clinical development

Middle dose tested hit the primary endpoint of the Phase II trial

People with sleep condition could be at an increased risk of adverse outcomes from COVID-19

Researchers found combination treatment showed promise against a range of cancer types

Lumevoq is designed to treat vision loss associated with Leber Hereditary Optic Neuropathy

World Evidence-based Healthcare Day takes place on 20 October

Report also highlights the impact of COVID-19 on the physical and mental health of doctors

Pharmacists, GPs and patients join arms to call for law change

Agreement grants MSD access to investigational ADC and a small molecule tyrosine kinase inhibitor